Generic Sensipar Cipla Challenges Legality of AmgenTeva Patent Settlement

Generic Sensipar: Cipla Challenges Legality of Amgen/Teva Patent Settlement

Cipla, which previously settled with Amgen, alleges Sensipar's formulation patent is currently unenforceable due to ‘patent misuse,’ and brand sponsor’s...

More From BioPortfolio on "Generic Sensipar: Cipla Challenges Legality of Amgen/Teva Patent Settlement"